Follow
Cancer
Cancer: is a disease in which abnormal cells divide uncontrollably and destroy body tissue. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues.
MAR 23, 2023 | 8:00 AM
Date: March 23, 2023 Time: 8:00am (PDT), 11:00am (EDT), 8:00pm (CEST) Across clinical oncology applications, from molecular testing to cancer research the ability to identify potentially act...
MAR 22, 2023 | 9:00 AM
We have developed 3D-shaped hydrogel microparticle platforms to capture cells, as well as isolate and label their secretions. These “lab on a particle” systems enable sorting cel...
MAR 22, 2023 | 6:00 AM
Our lab has developed a novel platform for droplet sorting that can be used to sort enzymes by activity, and cells by metabolism. It is a passive technique that utilizes no excitation laser,...
MAR 16, 2023 | 9:00 AM
Date: March 16, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Problem Screening greater than 10 pathogens or SNPs in a sample is challenging due to limitations in fluorescence colo...
MAR 16, 2023 | 8:00 AM
Date: March 16, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Protein polymerization underpins major biological processes, such as cell division and intracellular transport, while und...
MAR 08, 2023 | 8:00 AM
Date: March 08, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Engineered nucleases like the CRISPR-Cas9 system provide researchers with powerful tools for the manipulation of the geno...
MAR 01, 2023 | 8:00 AM
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Characterizing metastasis remains key for understanding and eradicating cancer. The study of circulating tumor cells (CTC...
FEB 22, 2023 | 6:00 AM
Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious di...
FEB 22, 2023 | 5:30 AM
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of metabolic disorders affecting 25% of our global population. 20% of NAFLD patients go on to develop Non-alcoholic steatohepatitis (N...
FEB 21, 2023 | 8:00 AM
Date: February 21, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Cancer is a highly heterogeneous disease in need of accurate and non-invasive diagnostic tools. Here, we describe a no...
FEB 15, 2023 | 7:00 AM
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
FEB 08, 2023 | 9:00 AM
Date: February 08, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Understanding cell-to-cell interactions in a tumor microenvironment are increasingly challenging due to the complexit...
JAN 25, 2023 | 10:00 AM
Date: January 25, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) The field of proteomics is poised for a single-molecule revolution – enabling more comprehensive analysis of the...
JAN 25, 2023 | 8:00 AM
Date: January 25, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Allogeneic hematopoietic cell transplantation (HCT) is curative for hematological diseases; however, is also associated...
DEC 14, 2022 | 12:00 PM
Date: December 14, 2022 Time: 12:00pm (PST), 3:00pm (EST), 9:00pm (CET) Adopting novel technologies is essential for improving patient outcomes, but the key to sustainable success is through...
DEC 07, 2022 | 9:00 AM
Date: December 07, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Join us for an exciting live panel webinar, as we celebrate the 60th anniversary of Gibco Cell Culture. The panelists...
NOV 17, 2022 | 7:00 AM
Date: November 17, 2022 Time: 7:00am (PST), 10:00am (EST), 4:00pm (CET) In order to truly understand cell biology, researchers need easy-to-use tools that preserve the natural complexity of...
NOV 16, 2022 | 7:00 PM
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
NOV 16, 2022 | 9:00 AM
Date: November 16, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) No more estimating. No more ranges. No more uncertainty. While PDX tumor models are crucial for gaining predictive ins...
NOV 09, 2022 | 8:00 AM
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
NOV 09, 2022 | 3:00 AM
Date: November 9, 2021 Time: 3:00am (PDT), 6:00am (EDT), 12:00pm (CEST) An increasing number of cervical cancer screening programs are converting from cytology to primary HPV-based organiz...
NOV 07, 2022 | 9:00 PM
Date: November 8, 2022 Time: 1:00pm (SGT), 12:00pm (EST), 6:00am (CET) Antibodies are vital tools in many of the laboratory techniques that are used...
NOV 03, 2022 | 6:00 AM
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
MAR 16, 2023 | 9:00 AM
Date: March 16, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Problem Screening greater than 10 pathogens or SNPs in a sample is challenging due to limitations in fluorescence colo...
MAR 16, 2023 | 8:00 AM
Date: March 16, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Protein polymerization underpins major biological processes, such as cell division and intracellular transport, while und...
MAR 08, 2023 | 8:00 AM
Date: March 08, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Engineered nucleases like the CRISPR-Cas9 system provide researchers with powerful tools for the manipulation of the geno...
MAR 01, 2023 | 8:00 AM
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Characterizing metastasis remains key for understanding and eradicating cancer. The study of circulating tumor cells (CTC...
FEB 22, 2023 | 6:00 AM
Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious di...